New England Journal of Medicine · 2013 · 1K citations · 23 references
Omalizumab diminished clinical symptoms and signs of chronic idiopathic urticaria in patients who had remained symptomatic despite the use of approved doses of H-antihistamines. (Funded by Genentech and Novartis Pharma; ClinicalTrials.gov number, NCT01292473.).
23
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria
Torsten Zuberbier, Riccardo Asero, Carsten Bindslev‐Jensen et al. · Allergy · 2009 · 522 citations
The impact of chronic urticaria on the quality of life
B. F. O’Donnell, Frances Lawlor, J. SIMPSON et al. · British Journal of Dermatology · 1997 · 465 citations